Clinical Trials
8 trialsNCT05236647 2025-03-06
SIM
University Hospital, Akershus
Phase 3 Completed
NCT03825887 2021-08-02
PCA
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT00003687 2020-04-03
Treatment for Chronic Pain in Patients With Advanced Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT01675622 2018-05-21
Immediate-Release Oxycodone Capsules Study in Cancer Pain
Mundipharma (China) Pharmaceutical Co. Ltd
Phase 3 Completed
NCT00201539 2015-04-08
Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients
Norwegian University of Science and Technology
Phase 3 Completed
NCT01309386 2013-03-13
A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants
Janssen Pharmaceutical K.K.
Phase 3 Completed
NCT01367418 2012-03-19
AIMS
Örebro University, Sweden
Phase 3 Completed
NCT00410540 2010-04-27
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Alza Corporation, DE, USA
Phase 3 Completed